期刊文献+

1例基因多态性引起伏立康唑致视觉异常的病例分析及处理 被引量:4

下载PDF
导出
摘要 伏立康唑属三唑类广谱抗真菌药,对曲霉菌有良好的抗菌活性,其抗真菌机制是通过抑制细胞色素P450(CYP450)依赖性14-α-固醇去甲基酶的活性,从而抑制功能性真菌膜的形成和维持真菌生长的甾醇的生物合成,抑制细胞膜合成,造成细胞破裂死亡^([1]),在临床的实践使用过程中,不时会有其眼部不良反应的报道。以下通过对1例静脉滴注伏立康唑引起视觉异常的病例分析,为临床药师及时判断和处理此类药物不良反应提供参考。
作者 曹季平 陈霞
出处 《中南药学》 CAS 2020年第7期1257-1258,共2页 Central South Pharmacy
  • 相关文献

参考文献2

二级参考文献32

  • 1李艳红,王永华,李燕,杨凌.MDR1基因多态性及其临床相关性研究进展(英文)[J].Acta Genetica Sinica,2006,33(2):93-104. 被引量:11
  • 2重症患者侵袭性真菌感染诊断与治疗指南(2007)[J].中华内科杂志,2007,46(11):960-966. 被引量:429
  • 3FDA. Background document for the Antiviral Drug Products Adviso- ry Committee meeting October 4, 2001 : Voriconazole tablets and voriconazole injection [ EB/OL ]. 2002 - 09 - 20 [ 2015 - 10 - 21 ]. http:/1 - fda. gov/ohrms/dockets/a - Oll/briefing/3792b_02 FDA - vorieonazole, htm.
  • 4FDA Antiviral Drugs Advisory Committee. Briefing document for voriconazole (oral and intravenous formulations ) [ EB/OL ]. 2001 - 10 -04 [2015 - 10 - 21 ]. http://www, fda. gov/ohrms/ docket s/AC/01/briefing'3792 b2 _01 _Pfizer. pdf.
  • 5SCHOLZ I, OBERWITTLER H, RIEDEL K D, et al. Pharmacoki- netics, metabolism and bioavailability of the triazole antifungal agent voficonazole in relation to CYP2C19 genotype [ J ]. Br J of Clin Pharmacol, 2009,68(6) :906 -915.
  • 6LEE S, KIM B H, NAM W S, et al. Effect of CYP2C19 polymor- phism on the pharmacokinetics of voriconazole after single and mul- tiple doses in healthy volunteers [ J ]. J Clin Pharmacol, 2012,52 (2) :195 -203.
  • 7WEISS J, TEN HOEVEL M M, BURHENNE J, et al. CYP2C19 genotype is a major factor contributing to the highly variable pharma- cokinetics of voriconazole [ J ]. J Clin Pharmacol, 2009,49 ( 2 ) : 196 - 204.
  • 8GOLDSTEIN J A. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily [ J ]. Br J Clin Pharmacol, 2001,52 (4) :349 -355.
  • 9SIMS C, RISINGER C, DAHL M L, et al. A common novel CYP2CI9 gene variant causes ultra- rapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants[J]. Clin Phar- macol Ther, 2006,79(1) :103 -113.
  • 10CHEN L, QIN S, XIE J, et al. Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of China's Mainland [ J ]. Phaogenomics, 2008,9 ( 6 ) : 691 - 702.

共引文献21

同被引文献46

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部